Home  »  Hot Stocks   »  The Chart for Marrone Bio Innovations Inc. (MBII) ...

The Chart for Marrone Bio Innovations Inc. (MBII) Is Flashing Mixed Signals

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Marrone Bio Innovations Inc. (NASDAQ:MBII) went up by 11.42% from its latest closing price compared to the recent 1-year high of $2.90. The company’s stock price has collected -5.28% of loss in the last five trading sessions. Press Release reported on 01/06/22 that Marrone Bio’s Inventory Line of Credit Increased to Support Sales and Manufacturing Growth

Is It Worth Investing in Marrone Bio Innovations Inc. (NASDAQ :MBII) Right Now?

Plus, the 36-month beta value for MBII is at 0.30. Opinions of the stock are interesting as 4 analysts out of 4 who provided ratings for Marrone Bio Innovations Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The average price from analysts is $2.63, which is $1.65 above the current price. MBII currently public float of 174.04M and currently shorts hold a 0.76% ratio of that float. Today, the average trading volume of MBII was 358.22K shares.

MBII’s Market Performance

MBII stocks went down by -5.28% for the week, with a monthly jump of 1.26% and a quarterly performance of -24.98%, while its annual performance rate touched -45.20%. The volatility ratio for the week stands at 6.09% while the volatility levels for the past 30 days are set at 8.09% for Marrone Bio Innovations Inc.. The simple moving average for the period of the last 20 days is 8.54% for MBII stocks with a simple moving average of -35.45% for the last 200 days.

Analysts’ Opinion of MBII

Rodman & Renshaw, on the other hand, stated in their research note that they expect to see MBII reach a price target of $3.50. The rating they have provided for MBII stocks is “Buy” according to the report published on March 16th, 2016.

MBII Trading at 3.59% from the 50-Day Moving Average

After a stumble in the market that brought MBII to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -73.05% of loss for the given period.

Volatility was left at 8.09%, however, over the last 30 days, the volatility rate increased by 6.09%, as shares surge +6.09% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -16.82% lower at present.

During the last 5 trading sessions, MBII fell by -2.40%, which changed the moving average for the period of 200-days by -64.98% in comparison to the 20-day moving average, which settled at $0.7221. In addition, Marrone Bio Innovations Inc. saw -2.61% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at MBII starting from Marrone Pamela G, who sale 24,510 shares at the price of $1.02 back on Aug 24. After this action, Marrone Pamela G now owns 2,208,363 shares of Marrone Bio Innovations Inc., valued at $25,000 using the latest closing price.

Marrone Pamela G, the Director of Marrone Bio Innovations Inc., sale 17,858 shares at $1.45 during a trade that took place back on Aug 09, which means that Marrone Pamela G is holding 2,232,873 shares at $25,894 based on the most recent closing price.

Stock Fundamentals for MBII

Current profitability levels for the company are sitting at:

  • -44.81 for the present operating margin
  • +59.60 for the gross margin

The net margin for Marrone Bio Innovations Inc. stands at -52.56. The total capital return value is set at -29.90, while invested capital returns managed to touch -40.37. Equity return is now at value -46.80, with -18.40 for asset returns.

Based on Marrone Bio Innovations Inc. (MBII), the company’s capital structure generated 102.32 points at debt to equity in total, while total debt to capital is 50.57. Total debt to assets is 39.58, with long-term debt to equity ratio resting at 69.50. Finally, the long-term debt to capital ratio is 34.35.

>> 7 Top Picks for the Post-Pandemic Economy <<

When we switch over and look at the enterprise to sales, we see a ratio of 3.41, with the company’s debt to enterprise value settled at 0.16. The receivables turnover for the company is 4.79 and the total asset turnover is 0.50. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.41.

Leave a Comment

Your email address will not be published. Required fields are marked *




Download Free eBook For


100% free. stop anytime no spam